E
Rocket Pharmaceuticals, Inc. RCKT
$3.41 -$0.135-3.81% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses 25.02M 28.45M 25.34M 27.11M 27.37M
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 67.68M 64.39M 62.69M 69.42M 73.71M
Operating Income -67.68M -64.39M -62.69M -69.42M -73.71M
Income Before Tax -68.92M -61.33M -60.33M -66.72M -69.65M
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -68.92M -61.33M -60.33M -66.72M -69.65M
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -68.92M -61.33M -60.33M -66.72M -69.65M
EBIT -67.68M -64.39M -62.69M -69.42M -73.71M
EBITDA -65.10M -61.40M -60.33M -67.04M -71.34M
EPS Basic -0.62 -0.56 -0.62 -0.71 -0.74
Normalized Basic EPS -0.38 -0.36 -0.39 -0.46 -0.48
EPS Diluted -0.62 -0.56 -0.62 -0.71 -0.74
Normalized Diluted EPS -0.38 -0.36 -0.39 -0.46 -0.48
Average Basic Shares Outstanding 111.02M 110.09M 97.53M 94.16M 93.75M
Average Diluted Shares Outstanding 111.02M 110.09M 97.53M 94.16M 93.75M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --